Morphine-induced nitric oxide production in isolated, iris-ciliary bodies

Experimental Eye Research

Volumn 89, Issue 5, 2009, Pages 660-664

  Dortch Carnes, Juanita ^a   Russell Randall, Karen ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

iris ciliary body; morphine; nitric oxide; opioid receptors

Indexed keywords

GLUTATHIONE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; OPIATE RECEPTOR;

ANIMAL TISSUE; AQUEOUS HUMOR FLOW; AQUEOUS HUMOR FORMATION; ARTICLE; CILIARY BODY; CONCENTRATION RESPONSE; CONTROLLED STUDY; IRIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; CILIARY BODY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUTATHIONE; IRIS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RABBITS; RECEPTORS, OPIOID; TIME FACTORS; UP-REGULATION;

EID: 70349439133     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.06.007     Document Type: Article

References (48)

1. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 (2001) 593-615
2. Barany E.H. The mode of action of pilocarpine on outflow resistance in the eye of a primate. Invest. Ophthalmol. 1 (1962) 712-727
3. Becker B. Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits. Invest. Ophthalmol. Vis. Sci. 31 (1990) 1647-1649
4. Bonfiglio V., Bucolo C., Camillieri G., and Drago F. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits. Eur. J. Pharmacol. 534 1-3 (2006) 227-232
5. Brubaker R.F. Targeting outflow facility in glaucoma management. Surv. Ophthalmol. 48 (2003) S17-S20
6. Coussons-Read M.E., and Giese S. Acute morphine treatment alters cellular immune functions in the lungs of healthy rats. Int. Immunopharmacol. 1 (2001) 1571-1581
7. Ding K.-H., and Abdel-Latif A.A. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris spincter smooth muscles. Invest. Ophthalmol. Vis. Sci. 35 (1997) 2515-2520
8. Dortch-Carnes J., and Russell K.R. Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide. Pharmacology 77 (2006) 17-24
9. Dortch-Carnes J., and Russell K. Morphine-stimulated nitric oxide release in rabbit aqueous humor. Exp. Eye Res. 84 1 (2007) 185-190
10. Drago F., Panissidi G., Bellomio F., Dal Bello A., Aguglia E., and Gorgone G. Effects of opiates and opioids on intraocular pressure of rabbits and humans. Clin. Exp. Pharmacol. Physiol. 12 (1985) 107-113
11. Fanciullacci M., Boccuni M., Pietrini U., and Sicuteri F. The naloxone conjunctival test in morphine addiction. Eur. J. Pharmacol. 61 (1980) 319-320
12. Geyer O., Podos S.M., and Mittag T. Nitric oxide synthase activity in tissues of the bovine eye. Graefes Arch. Clin. Exp. Ophthalmol. 235 12 (1997) 786-793
13. Gilbert H.F. Biological disulfides: the third messenger?. J. Biol. Chem. 257 (1982) 12086-12091
14. Gionnini T.L., Liu Y.F., Park Y.H., Hiller J.M., and Simon E.J. Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding. Possible role in receptor activation. J. Mol. Recognit. 2 1 (1989) 44-48
15. Gioannini T.L., Liu J.F., Hiller J.M., and Simon E. Disulfide bonds in opiate receptors. J. Mol. Recognit. 2 (1990) 444-448
16. 1 receptor agonists is mediated by iNOS. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H2251-H2257
17. Ignarro L.J. Nitric oxide-a novel signal transduction mechanism for transcellular communication. Hypertension 16 (1990) 477-483
18. Ignarro L.J., Cirino G., Casini A., and Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34 (1999) 879-886
19. Korenfeld M.S., and Becker B. Atrial natriuretic peptides: effects on intraocular pressure, cGMP, and aqueous flow. Invest. Ophthalmol. Vis. Sci. 30 (1989) 2385-2392
20. Kowalski J. Augmenting effect of opioids on nitrite production by stimulated murine macrophages. Neuropeptides 32 3 (1998) 287-291
21. Krupin T., Wax M., and Moolchandani J. Aqueous production. Trans. Ophthalmol. Soc. UK 105 (1986) 111-116
22. Lee H.K., and Wang S.C. Mechanism of morphine-induced miosis in the dog. J. Pharmacol. Exp. Ther. 192 (1975) 415-431
23. Leopold I.H., and Comroe J.H. Effect of intramuscular administration of morphine, atropine, scopolamine and neostigmine on the human eye. Arch. Ophthalmol. 40 (1948) 285-291
24. Lepple-Wienhues A., Stahl F., and Wiederholt M. Differential smooth muscle-like contractile properties of trabecular meshwork and ciliary muscle. Exp. Eye Res. 53 (1991) 33-38
25. Liu Y.F., and Quirion R. Modulatory role of glutathione on μ-opioid, substance P/neurokinin-1, and kainic acid receptor binding sites. J. Neurochem. 59 (1992) 1024-1032
26. Llobet A., Gasull X., and Gual A. Understanding trabecular meshwork physiology: a key to the control of intraocular pressure?. News Physiol. Sci. 18 (2003) 205-209
27. Makman M.H., Dobrenis K., Downie S., Lyman W.D., and Dvorkin B. Presence of opiate alkaloid-selective μ3 in cultured astrocytes and in brain and retina. Adv. Exp. Biol. Med. 402 (1996) 23-28
28. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., LeMeur M., Dolle P., Tzavara E., Honoune J., Roques B.P., and Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 6603 (1996) 819-823
29. Millar J.C., Shahidullah M., and Wilson W.S. Atriopeptin lowers aqueous humor formation and intraocular pressure and elevates ciliary cyclic GMP but lacks uveal vascular effects in the bovine perfused eye. J. Ocul. Pharmacol. Ther. 13 (1997) 1-11
30. Moncada S., Palmer R.M.J., and Higgs E.A. Biosynthesis of nitric oxide from l-arginine: a pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38 (1989) 1709-1715
31. Moncada S., and Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 30 (1993) 2002-2012
32. Moore T.T., and Potter D.E. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp. Eye Res. 73 (2001) 167-178
33. Murray R.B., Adler M.W., and Korczyn A.D. Minireview. The pupillary effects of opioids. Life Sci. 33 (1983) 495-509
34. Myashita H. Ocular tension. Zentralblatt fur Biochemie und Biophysik 15 (1913) 95-98
35. Nathanson J.A. Atriopeptin-activated guanylate cyclase in the anterior segment: identification, localization, and the effects of atriopeptins on IOP. Invest. Ophthalmol. Vis. Sci. 28 (1987) 1357-1364
36. Nieto-Fernandez F.E., Mattocks D., Cavani F., Salzet M., and Stefano G.B. Morphine coupling to invertebrate immunocyte nitric oxide release is dependent on intracellular calcium transients. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 123 3 (1999) 295-299
37. Rebrova T.Y., Maslov L.N., Lishmanov A.Y., and Tam S.V. Stimulation of mu and delta-opiate receptors and tolerance of isolated heart to oxidative stress: the role of NO-synthase. Biochemistry Mosc. 66 4 (2001) 422-428
38. Rialas C.M., Weeks B., Cadet P., Goumon Y., and Stefano G.B. Nociceptin, endomorphin-1 and -2 do not interact with invertebrate immune and neural mu3 opiate receptor. Acta Pharmacol. Sin. 21 6 (2000) 516-520
39. Russell K.R., Wang D.R., and Potter D.E. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp. Eye Res. 70 (2000) 675-682
40. Russell K.R., and Potter D.E. Dynorphin modulates ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp. Eye Res. 75 (2002) 259-270
41. Stefano G.B. The μ3 opiate receptor subtype. Pain Forum 8 (1999) 206-209
42. Stefano G.B., Zhu W., Cadet P., Mantione K., Bilfinger T.V., Bianchi E., and Guarna M. A hormonal role for endogenous opiate alkaloids: vascular tissues. Neuro endocrinol. Lett. 23 1 (2002) 21-26
43. Sun X., Ma S., Zang Y., Lu S., Guo H., Bi H., Wang Y., Ma H., Ma X., and Pei J. Vasorelaxing effect of U50, 488H in pulmonary artery and underlying mechanism in rats. Life Sci. 78 (2006) 2516-2522
44. Welters I.D., Menzebach A., Goumon Y., Langefeld T.W., Teschemacher H., Hempelmann G., and Stefano G.B. Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism. J. Neuroimmunol. 111 1-2 (2000) 139-145
45. Wiederholt M., Sturm A., and Lepple-Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest. Ophthalmol. Vis. Sci. 35 (1994) 2515-2520
46. Wiederholt M., Bielka S., Schweig F., Lutjen-Drecoll E., and Lepple-Wienhues A. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp. Eye Res. 61 (1995) 223-234
47. Wiederholt M., Dorschner N., and Groth J. Effect of diuretics, channel modulators and signal interceptors on contractility of the trabecular meshwork. Ophthalmologica 211 (1997) 153-160
48. Yahyavi-Firouz-Abadi N., Tahsili-Fahadan P., and Ostad S.N. Effect of mu and kappa opioids on injury-induced microglial accumulation in leech CNS: involvement of the nitric oxide pathway. Neuroscience 144 3 (2007) 1075-1086